- $74.45m
 - $114.06m
 - $151.28m
 
- 62
 - 62
 - 51
 - 61
 
Annual income statement for AstroNova, fiscal year end - January 31st, USD millions except per share, conversion factor applied.
2021 January 31st  | 2022 January 31st  | 2023 January 31st  | 2024 January 31st  | 2025 January 31st  | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M | 
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K | 
| Standards: | USG | USG | USG | USG | USG | 
| Status: | Final | Final | Final | Final | Final | 
| Revenue | |||||
| Total Revenue | 116 | 117 | 143 | 148 | 151 | 
| Cost of Revenue | |||||
| Gross Profit | 41.4 | 43.7 | 48.2 | 53.7 | 52.7 | 
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 114 | 109 | 137 | 139 | 160 | 
| Operating Profit | 2.43 | 8.72 | 5.44 | 8.8 | -8.64 | 
| Total Net Non Operating Interest Income / Expense | |||||
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 2.18 | 7.03 | 3.41 | 6.07 | -12.3 | 
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1.28 | 6.43 | 2.66 | 4.69 | -14.5 | 
| Net Income Before Extraordinary Items | |||||
| Net Income | 1.28 | 6.43 | 2.66 | 4.69 | -14.5 | 
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1.28 | 6.43 | 2.66 | 4.69 | -14.5 | 
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.179 | 0.406 | 0.361 | 0.964 | -0.665 |